Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A (Natalie Breymeyer/Axios)
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
25/20
Brand Signal
6/15
Depth
4/15
5-Axis Cultural Radar
Natalie Breymeyer / Axios : Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A — Altis Labs, an AI software company for drug development, raised a $25 million Series A, CEO Felix Baldauf-Lenschen tells Axios Pro.
